Catheter Precision Inc. has announced a share issue that could lead to significant dilution for current investors. The company plans to issue 1,748,666 new shares of common stock, which will adjust the net tangible book value. As of March 31, 2025, the net tangible book value was reported at $(15.8) million, or $(1.71) per share. The share issuance is expected to bring this value to $(15.84) million, or $(1.44) per share. Additionally, the company has reserved 880,365 shares for future issuance under equity incentive plans. The issuance of these shares, along with the potential exercise of stock options and warrants, may further dilute the ownership of current shareholders. Catheter Precision Inc. plans to offer 4,333,333 shares at the market, with the last reported sale price being $0.30 per share, aiming to raise approximately $1.3 million in gross proceeds.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.